These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15560111)

  • 21. Global programme to eliminate lymphatic filariasis: progress report, 2011.
    Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
    [No Abstract]   [Full Text] [Related]  

  • 22. Global programme to eliminate lymphatic filariasis: progress report for 2012.
    Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
    [No Abstract]   [Full Text] [Related]  

  • 23. Conclusions of the meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, November 2007.
    Wkly Epidemiol Rec; 2008 Sep; 83(37):341-7. PubMed ID: 18788147
    [No Abstract]   [Full Text] [Related]  

  • 24. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2012 Nov; 87(48):478-82. PubMed ID: 23213667
    [No Abstract]   [Full Text] [Related]  

  • 25. Mass treatment of filariasis in New Guinea.
    Addiss DG
    N Engl J Med; 2003 Mar; 348(12):1179-81; author reply 1179-81. PubMed ID: 12646679
    [No Abstract]   [Full Text] [Related]  

  • 26. [Management of lymphoedema due to lymphatic filariasis: experience of the Handicap International Federation].
    Brantus P
    Med Sante Trop; 2013 May; 23(2):231. PubMed ID: 24001647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 Sep; 78(36):315-7. PubMed ID: 14518107
    [No Abstract]   [Full Text] [Related]  

  • 28. [Medical treatment of lymphatic filariasis].
    Hovette P; Laroche R; Verrot D; Molinier S; Touze JE
    Med Trop (Mars); 1991; 51(1):87-90. PubMed ID: 2072855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silver bullets, shotguns, and integrative community-based approach to lymphedema from lymphatic filariasis in India.
    Kaur V
    Lymphology; 2007 Jun; 40(2):96; author reply 97-8. PubMed ID: 17853621
    [No Abstract]   [Full Text] [Related]  

  • 30. Silver bullets, shotguns, and integrative community-based approach to lymphedema from lymphatic filariasis in India.
    Manokaran G
    Lymphology; 2007 Jun; 40(2):95-6; author reply 97-8. PubMed ID: 17853620
    [No Abstract]   [Full Text] [Related]  

  • 31. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatic filariasis and onchocerciasis.
    Taylor MJ; Hoerauf A; Bockarie M
    Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
    Sahoo PK; Satapathy AK; Michael E; Ravindran B
    Am J Trop Med Hyg; 2005 Nov; 73(5):877-80. PubMed ID: 16282297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment-seeking behavior and treatment practices of lymphatic filariasis patients with lymphoedema in the Colombo district, Sri Lanka.
    Wijesinghe RS; Wickremasinghe AR; Ekanayake S; Perera MS
    Asia Pac J Public Health; 2008; 20(2):129-38. PubMed ID: 19124306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elimination of lymphatic filariasis in India.
    Sabesan S; Ravi R; Das PK
    Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of chronic manifestations of filariasis.
    Dandapat MC; Mohapatro SK; Dash DM
    J Indian Med Assoc; 1986 Jul; 84(7):210-5. PubMed ID: 3794355
    [No Abstract]   [Full Text] [Related]  

  • 37. Situational analysis of lymphatic filariasis morbidity in Ahanta West District of Ghana.
    Stanton MC; Best A; Cliffe M; Kelly-Hope L; Biritwum NK; Batsa L; Debrah A
    Trop Med Int Health; 2016 Feb; 21(2):236-44. PubMed ID: 26584839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of parasite drug resistance in human lymphatic filariasis.
    Cobo F
    Rev Esp Quimioter; 2016 Dec; 29(6):288-295. PubMed ID: 27858056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2004 Oct; 79(40):358-65. PubMed ID: 15631012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.